Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency

Accordance Between Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency, in Patients Hospitalised in Internal Medicine Service and 65 Years Old and More

Sponsors

Lead Sponsor: Lille Catholic University

Source Lille Catholic University
Brief Summary

Transferrin saturation coefficient and ferritinemia in diagnosis of iron deficiency

Overall Status Completed
Start Date June 6, 2019
Completion Date September 30, 2019
Primary Completion Date September 30, 2019
Study Type Observational
Primary Outcome
Measure Time Frame
Agreement between Transferrin Saturation Coefficient (TSC) and ferritinemia dosage Day one
Secondary Outcome
Measure Time Frame
Prevalence of iron deficiency with and without anaemia Day one
Prevalence of etiologies of iron deficiency Day one
Prevalence of iron deficiency in patients with anticoagulant and platelet aggregation inhibitor Day one
Enrollment 136
Condition
Intervention

Intervention Type: Diagnostic Test

Intervention Name: biologic analysis (ferritinemia, transferrin saturation coefficient)

Description: Each patient will follow a blood test in order to compare between ferritinemia and transferrin saturation coefficient in iron deficiency diagnosis

Arm Group Label: Hospitalized patients aged 65 and over

Eligibility

Sampling Method: Non-Probability Sample

Criteria:

Inclusion Criteria:

- ≥ 65 years old

- Patient hospitalized in the internal medicine and geriatry service

- Patient affiliated with a social security scheme

- Patient signed an Informed consent

Exclusion Criteria:

- Risk benefit balance not in favor of iron deficiency check-up

- Patient in palliative care

Gender: All

Minimum Age: 65 Years

Maximum Age: N/A

Healthy Volunteers: No

Overall Official
Last Name Role Affiliation
Hélène Bulckaen, MD Principal Investigator Groupement des Hôpitaux de l'Institut Catholique de Lille
Location
Facility: Saint-Philibert hospital
Location Countries

France

Verification Date

October 2019

Responsible Party

Type: Sponsor

Has Expanded Access No
Condition Browse
Arm Group

Label: Hospitalized patients aged 65 and over

Description: - Patients aged 65 and over hospitalized in the department of Internal Medicine and Geriatry

Acronym CarenceMartial
Patient Data No
Study Design Info

Observational Model: Other

Time Perspective: Prospective

Source: ClinicalTrials.gov